Carmell Co. (NASDAQ:CTCX – Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 23,500 shares, an increase of 64.3% from the March 31st total of 14,300 shares. Based on an average trading volume of 6,200 shares, the days-to-cover ratio is currently 3.8 days. Approximately 0.2% of the company’s stock are sold short.
Institutional Trading of Carmell
A number of large investors have recently made changes to their positions in CTCX. Carnegie Mellon University acquired a new stake in shares of Carmell in the 3rd quarter valued at about $371,000. Cookson Peirce & Co. Inc. acquired a new stake in shares of Carmell in the 3rd quarter valued at about $54,000. Meteora Capital LLC acquired a new stake in shares of Carmell in the 3rd quarter valued at about $6,416,000. Linden Advisors LP acquired a new stake in shares of Carmell in the 3rd quarter valued at about $270,000. Finally, Hubbell Strickland Wealth Management LLC acquired a new stake in shares of Carmell in the 1st quarter valued at about $32,000. 24.22% of the stock is owned by institutional investors and hedge funds.
Carmell Stock Performance
CTCX opened at $2.09 on Friday. Carmell has a one year low of $1.70 and a one year high of $13.31. The business’s 50-day simple moving average is $2.64 and its 200-day simple moving average is $2.94.
Carmell Company Profile
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Stories
- Five stocks we like better than Carmell
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Invest in Insurance Companies: A Guide
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Stock Average Calculator
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.
